Insight Molecular Diagnostics (IMDX) Net Income towards Common Stockholders Growth (1y) (2016 - 2026)
Insight Molecular Diagnostics (IMDX) Net Income towards Common Stockholders Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | -159.32% |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 9.95% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 7.86% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 14.74% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 57.67% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | -44.49% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -27.15% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 2.29% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | 3.59% |
| 10 | Insight Molecular Diagnostics | 4.44 Mn | -24.49 Mn | 15,000.00 | 33.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.85% |
| Dec 31, 2025 | 31.50% |
| Sep 30, 2025 | 19.56% |
| Jun 30, 2025 | -112.38% |
| Mar 31, 2025 | 28.54% |
| Dec 31, 2024 | -152.55% |
| Sep 30, 2024 | -101.78% |
| Jun 30, 2024 | 46.93% |
| Mar 31, 2024 | -389,545.14% |
| Dec 31, 2023 | -246.04% |
| Sep 30, 2023 | 30.54% |
| Jun 30, 2023 | -3.25% |
| Mar 31, 2023 | 100.02% |
| Dec 31, 2022 | 125.32% |
| Sep 30, 2022 | 30.24% |
| Jun 30, 2022 | 20.21% |
| Mar 31, 2022 | -162.59% |
| Dec 31, 2021 | -441.50% |
| Sep 30, 2021 | -103.45% |
| Jun 30, 2021 | -51.68% |